Inhibition of gene expression, and overexpression

RB Rohit Bose
WK Wouter R. Karthaus
JA Joshua Armenia
WA Wassim Abida
PI Phillip J. Iaquinta
ZZ Zeda Zhang
JW John Wongvipat
EW Elizabeth V. Wasmuth
NS Neel Shah
PS Patrick S. Sullivan
MD Michael G. Doran
PW Ping Wang
AP Anna Patruno
YZ Yilin Zhao
DZ Deyou Zheng
NS Nikolaus Schultz
CS Charles L. Sawyers
request Request a Protocol
ask Ask a question
Favorite

ERF shRNA knockdown experiments were performed by infection and puromycin selection of cells with lentivirus containing the miR-E based SGEP or SGEN vectors24 gifted by J. Zuber containing the following guide sequences: shErf_m: TTGAACTTGTAGGTGAACCGTT, shERF_2: TTGTTTTGAATACATTCTCCAG, shERF_1: TTGAAATTGAACTTGTAGGTGA, shNT was previously described as Ren.713 targeting Renilla luciferase24. ERG shRNA knockdown experiments were performed by infection and neomycin selection of cells with lentivirus containing the Tet-pLKO-neo vector gifted by D. Wiederschain (Addgene plasmid 21916) using the previously published ERG shRNA and non-targeting sequences25. For Tet-responsive reporters, either dimethylsulfoxide (DMSO) vehicle or doxycycline (Sigma) was added at 100 ng ml−1. CRISPR–Cas9 experiments were performed by infection and puromycin selection of cells with lentivirus containing the lentiCRISPRv2 vector gifted by F Zhang (Addgene plasmid 52961) containing the following guide sequences chosen via the http://www.genome-engineering.org website: sgERG (GATAACTCTGCGCTCGTTCG), sgERFm (CCTGCCAAGCGATGACGCCC), and previously described sgNT26. Overexpression of cDNAs was achieved by the constitutive or Tet-inducible pLV-based lentiviral expression system.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A